The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
A range of new and promising targeted drugs currently under development for improved cancer therapy were presented during the 11th International Congress on Targeted Anticancer Therapies, Paris, 4–6 March 2013 (TAT 2013). TAT 2013 was attended by over 500 participants from 46 countries. More th...
Збережено в:
| Опубліковано в: : | Experimental Oncology |
|---|---|
| Дата: | 2013 |
| Автори: | , |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2013
|
| Теми: | |
| Онлайн доступ: | https://nasplib.isofts.kiev.ua/handle/123456789/145244 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013) / O. Samoilenko, S. Zaletok // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 231-235. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| Резюме: | A range of new and promising targeted drugs currently
under development for improved cancer therapy
were presented during the 11th International Congress
on Targeted Anticancer Therapies, Paris,
4–6 March 2013 (TAT 2013). TAT 2013 was attended
by over 500 participants from 46 countries. More than
60 plenary lectures and 70 posters, presented by leading
experts in clinical cancer research and drug development,
were devoted to dozens of emerging targeted
agents and new drug targets under development for
cancer therapy
|
|---|---|
| ISSN: | 1812-9269 |